スマートインスリンパッチ市場レポート：2030年までの動向、予測、競合分析

スマートインスリンパッチの動向と予測

世界のスマートインスリンパッチ市場は、2024年から2030年にかけてCAGR 5.6％で成長すると予測されます。この市場の主な促進要因は、便利でパーソナライズされた糖尿病管理ソリューションに対する需要の増加と、ウェアラブル技術とヘルスケアイノベーションの進歩です。世界のスマートインスリンパッチ市場の将来は、1型糖尿病市場と2型糖尿病市場における機会によって有望視されています。

スマートインスリンパッチ市場の洞察

Lucintel社は、基礎インスリンとボーラス・インスリンの両方のニーズをカバーする包括的な糖尿病管理により、予測期間中に基礎ボーラス・インスリンが最も高い成長を遂げると予測しています。

この市場において、2型糖尿病は、その高い有病率と幅広い患者層により、最大のセグメントであり続けると思われます。

北米は、先進的なヘルスケア・インフラと高い糖尿病有病率により、予測期間中に最も高い成長が見込まれています。

よくある質問

Q1.市場の成長予測は？

A1.スマートインスリンパッチの世界市場は、2024年から2030年にかけてCAGR 5.6%で成長する見込みです。

Q2.市場の成長に影響を与える主な促進要因は？

A2.この市場の主な促進要因は、便利でパーソナライズされた糖尿病管理ソリューションに対する需要の増加、ウェアラブル技術とヘルスケアイノベーションの進歩です。

Q3.市場の主要セグメントは？

A3.スマートインスリンパッチ市場の将来性は、1型糖尿病と2型糖尿病市場における機会により有望視されます。

Q4.市場の主要企業は？

A4.主なスマートインスリンパッチ企業は以下の通りです。

• Cequr
• Zenomics
• Medtronic
• Abbott Laboratories
• Dexcom

Q5.今後、最大となる市場セグメントは？

A5.Lucintelは、基礎インスリンとボーラスインスリンの両方のニーズをカバーする包括的な糖尿病管理のため、予測期間中に最も高い成長を示すと予測しています。

Q6.市場において、今後5年間に最大になると予想される地域は？

A6.北米は、高度なヘルスケアインフラと高い糖尿病有病率により、予測期間中に最も高い成長が見込まれます。

Q7.レポートのカスタマイズは可能？

A7.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界のスマートインスリンパッチ市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年～2030年の市場動向と予測分析

• マクロ経済動向（2018年～2023年）と予測（2024年～2030年）
• 世界のスマートインスリンパッチ市場動向（2018年～2023年）と予測（2024年～2030年）
• 世界のスマートインスリンパッチ市場、タイプ別
  • 基礎インスリン
  • ボーラスインスリン
  • 基礎ボーラスインスリン
• 世界のスマートインスリンパッチ市場、用途別
  • 1型糖尿病
  • 2型糖尿病

第4章 2018年～2030年の地域別の市場動向と予測分析

• 地域別の世界のスマートインスリンパッチ市場
• 北米のスマートインスリンパッチ市場
• 欧州のスマートインスリンパッチ市場
• アジア太平洋のスマートインスリンパッチ市場
• その他地域のスマートインスリンパッチ市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • タイプ別の世界のスマートインスリンパッチ市場の成長機会
  • 用途別の世界のスマートインスリンパッチ市場の成長機会
  • 地域別の世界のスマートインスリンパッチ市場の成長機会
• 世界のスマートインスリンパッチ市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のスマートインスリンパッチ市場の能力拡大
  • 世界のスマートインスリンパッチ市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• CeQur
• Zenomics
• Medtronic
• Abbott Laboratories
• Dexcom

Smart Insulin Patch Trends and Forecast

The future of the global smart insulin patch market looks promising with opportunities in the type 1 diabetes and type 2 diabetes markets. The global smart insulin patch market is expected to grow with a CAGR of 5.6% from 2024 to 2030. The major drivers for this market are increasing demand for convenient and personalized diabetes management solutions and advancements in wearable technology and healthcare innovation.

A more than 150-page report is developed to help in your business decisions.

Smart Insulin Patch by Segment

The study includes a forecast for the global smart insulin patch by type, application, and region.

Smart Insulin Patch Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Basal Insulin
• Bolus Insulin
• Basal-Bolus Insulin

Smart Insulin Patch Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Type 1 Diabetes
• Type 2 Diabetes

Smart Insulin Patch Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Smart Insulin Patch Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies smart insulin patch companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the smart insulin patch companies profiled in this report include-

• Cequr
• Zenomics
• Medtronic
• Abbott Laboratories
• Dexcom

Smart Insulin Patch Market Insights

Lucintel forecasts that basal-bolus insulin is expected to witness highest growth over the forecast period due to comprehensive diabetes management, covering both basal and bolus needs.

Within this market, type 2 diabetes will remain the largest segment due to its higher prevalence and broader patient base.

North America is expected to witness highest growth over the forecast period due to advanced healthcare infrastructure and high diabetes prevalenc.

Features of the Global Smart Insulin Patch Market

Market Size Estimates: Smart insulin patch market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Smart insulin patch market size by type, application, and region in terms of value ($B).

Regional Analysis: Smart insulin patch market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the smart insulin patch market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the smart insulin patch market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for smart insulin patch market?

Answer: The global smart insulin patch market is expected to grow with a CAGR of 5.6% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the smart insulin patch market?

Answer: The major drivers for this market are increasing demand for convenient and personalized diabetes management solutions and advancements in wearable technology and healthcare innovation.

Q3. What are the major segments for smart insulin patch market?

Answer: The future of the smart insulin patch market looks promising with opportunities in the type 1 diabetes and type 2 diabetes markets.

Q4. Who are the key smart insulin patch market companies?

Answer: Some of the key smart insulin patch companies are as follows.

• Cequr
• Zenomics
• Medtronic
• Abbott Laboratories
• Dexcom

Q5. Which smart insulin patch market segment will be the largest in future?

Answer: Lucintel forecasts that basal-bolus insulin is expected to witness highest growth over the forecast period due to comprehensive diabetes management, covering both basal and bolus needs.

Q6. In smart insulin patch market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to advanced healthcare infrastructure and high diabetes prevalenc.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the smart insulin patch market by type (basal insulin, bolus insulin, and basal-bolus insulin), application (type 1 diabetes and type 2 diabetes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Smart Insulin Patch Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Smart Insulin Patch Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Smart Insulin Patch Market by Type
  • 3.3.1: Basal Insulin
  • 3.3.2: Bolus Insulin
  • 3.3.3: Basal-Bolus Insulin
• 3.4: Global Smart Insulin Patch Market by Application
  • 3.4.1: Type 1 Diabetes
  • 3.4.2: Type 2 Diabetes

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Smart Insulin Patch Market by Region
• 4.2: North American Smart Insulin Patch Market
  • 4.2.2: North American Smart Insulin Patch Market by Application: Type 1 Diabetes, and Type 2 Diabetes
• 4.3: European Smart Insulin Patch Market
  • 4.3.1: European Smart Insulin Patch Market by Type: Basal Insulin, Bolus Insulin, and Basal-Bolus Insulin
  • 4.3.2: European Smart Insulin Patch Market by Application: Type 1 Diabetes, and Type 2 Diabetes
• 4.4: APAC Smart Insulin Patch Market
  • 4.4.1: APAC Smart Insulin Patch Market by Type: Basal Insulin, Bolus Insulin, and Basal-Bolus Insulin
  • 4.4.2: APAC Smart Insulin Patch Market by Application: Type 1 Diabetes, and Type 2 Diabetes
• 4.5: ROW Smart Insulin Patch Market
  • 4.5.1: ROW Smart Insulin Patch Market by Type: Basal Insulin, Bolus Insulin, and Basal-Bolus Insulin
  • 4.5.2: ROW Smart Insulin Patch Market by Application: Type 1 Diabetes, and Type 2 Diabetes

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Smart Insulin Patch Market by Type
  • 6.1.2: Growth Opportunities for the Global Smart Insulin Patch Market by Application
  • 6.1.3: Growth Opportunities for the Global Smart Insulin Patch Market by Region
• 6.2: Emerging Trends in the Global Smart Insulin Patch Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Smart Insulin Patch Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Smart Insulin Patch Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: CeQur
• 7.2: Zenomics
• 7.3: Medtronic
• 7.4: Abbott Laboratories
• 7.5: Dexcom